To buy shares in Shield Therapeutics Plc you will need a FCA regulated UK stock broker like AJ Bell, Hargreaves Lansdown or interactive investor where it currently costs 2.4p to buy one share in Shield Therapeutics Plc (as of 16:30 28-Apr-2025). Which is a change of 0.05p or 2.09% from the last closing price of 2.35p.
How To Buy Shield Therapeutics Plc Shares
It may seem complicated to buy shares for the first time, but it’s actually very easy. Follow these simple steps to buy shares in Shield Therapeutics Plc:
- Pick a stock broker (jump down to compare the best brokers for buying Shield Therapeutics Plc shares)
- Deposit funds (via bank transfer or debit card)
- Search for the company share symbol: (LON:STX)
- Choose the number of shares you want to buy (1 share currently costs 2.4p)
- Click buy (you can either trade immediately at “market” or set a “limit” to buy the shares cheaper if you think the price will go down)
- Track the performance of your Shield Therapeutics Plc shares in your account (this will show your profit and loss)
Shield Therapeutics Plc Share Price (STX) Quote & Overview
This section shows the most important aspects of the current Shield Therapeutics Plc STX:LN share price including price, change, bid/offer spread and volume.
- Shield Therapeutics Plc is currently worth Β£24,990,142 based on the last closing price of 2.35p with 1,645,432 shares traded.
- The most recent Shield Therapeutics Plc daily high has been 2.5p and daily low 2.3p.
- The Shield Therapeutics Plc share price 52 week high has been 5.87p and the 52 week low 1.23p.
Compare Brokers For Buying Shield Therapeutics Plc Stock
Is Now A Good Time To Buy Shield Therapeutics Plc Stock?
- Shield Therapeutics Plc’s EPS (earnings per share) are 0.05. A high EPS indicates strong profitability but may already be priced in, while a low EPS could signal weak earnings or a turnaround opportunity, requiring industry comparison.
- Shield Therapeutics Plc’s PE (price earnings ratio) is n/a. A low PE ratio may suggest undervaluation but could also indicate slow growth or risk, whereas a high PE ratio reflects high growth expectations but may signal overvaluation, necessitating a check on earnings sustainability.
The below Shield Therapeutics Plc share price analysis and market data includes key financials, earnings estimates, peer performance, dividends, news and a company profile that will give you an indication as to whether this stock is a buy, sell or hold.
Shield Therapeutics Plc (STX) Company Financials
This section shows current and previous Shield Therapeutics Plc STX:LN profit and loss information like revenue, income, expenses and earnings per share.
Shield Therapeutics Plc (STX) Financial Summary
This section allows you to compare Shield Therapeutics Plc STX:LN revenue, net income, cash flow statement and balance sheet against previous years. This can give you a good indication of how well a company is performing.
Shield Therapeutics Plc (STX) Share Price History
This section provides a visual and table view of the historic Shield Therapeutics Plc STX:LN share price including volume and VWAP which can be adjusted for splits and dividends.
Shield Therapeutics Plc (STX) Interactive Chart
This section allows you to compare Shield Therapeutics Plc STX:LN share price chart against other stocks as well as overlay key events like dividends, earnings and splits.
Shield Therapeutics Plc (STX) Dividends
This section analyses the historic and upcoming Shield Therapeutics Plc STX:LN dividend amounts, dates and yields. It provides a good indication of potential future and past profitability.
Shield Therapeutics Plc (STX) Corporate Events
This section shows key dates in Shield Therapeutics Plc STX:LN corporate calendar like company announcements, earnings releases, stock splits, and fundamental data chances like EPS updates.
Shield Therapeutics Plc (STX) Share Price Performance
This section shows key Shield Therapeutics Plc STX:LN share price levels like recent highs and lows, plus gives you tools to see average day traded volumes and institutional share holders major buys and sells.
Shield Therapeutics Plc (STX) Share Price News
This section shows new stories that are relevant to and may effect or explain changes in Shield Therapeutics Plc STX:LN share price.
Shield Therapeutics Plc (STX) Company Profile
This section provides corporate information on Shield Therapeutics Plc STX:LN, including what they do, their contact details, their CEO and auditor as well as in what sectors their shares trade.